Zobrazeno 1 - 10
of 47
pro vyhledávání: '"C Ortega Navarro"'
Autor:
C Ortega Navarro, A de Lorenzo Pinto, R García Sánchez, B Torroba Sanz, A Herranz Alonso, M Sanjurjo Sáez
Publikováno v:
Section 7: Post Congress additions.
Autor:
Pablo Díez-Villanueva, C Ortega-Navarro, Ana de Lorenzo-Pinto, Andrés Enríquez-Gómez, Clara Fernández-Cordón, Manuel Martínez-Sellés, José María de Miguel-Yanes
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(4)
Aims: The aim of this study was to test whether a newly designed polypharmacy-based scale would perform better than Charlson's Comorbidity Index (CCI) to predict outcomes in chronic complex adult patients after a reference Emergency Department (ED) v
Autor:
C Ortega-Navarro, Ana Herranz-Alonso, Beatriz Monje, María Sanjurjo-Sáez, Alvaro Gimenez-Manzorro
Publikováno v:
Revista Brasileira de Anestesiologia, Vol 69, Iss 3, Pp 259-265 (2019)
Revista Brasileira de Anestesiologia v.69 n.3 2019
Revista Brasileira de Anestesiologia
Sociedade Brasileira de Anestesiologia (SBA)
instacron:SBA
Brazilian Journal of Anesthesiology, Vol 69, Iss 3, Pp 259-265 (2019)
Revista Brasileira de Anestesiologia v.69 n.3 2019
Revista Brasileira de Anestesiologia
Sociedade Brasileira de Anestesiologia (SBA)
instacron:SBA
Brazilian Journal of Anesthesiology, Vol 69, Iss 3, Pp 259-265 (2019)
Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Meth
Autor:
Ana de Lorenzo-Pinto, María Sanjurjo-Sáez, José Luis Revuelta-Herrero, Raquel García-Sánchez, Javier Anguita-Velasco, C Ortega-Navarro
Publikováno v:
International Journal of Clinical Pharmacy. 41:1143-1147
Background Severe non-chemotherapy drug-induced neutropenia is a rare idiosyncratic drug reaction that is considered potentially fatal. Objective To report, in terms of drug safety surveillance, the results of an institutional strategy for NCDIN. Met
Autor:
María Sanjurjo-Sáez, Beatriz Monje, Alvaro Gimenez-Manzorro, Ana Herranz-Alonso, C Ortega-Navarro
Publikováno v:
Brazilian Journal of Anesthesiology. 69:259-265
Resumo Justificativa A Comissao para o Manejo da Dor estabeleceu um plano de melhoria no controle da dor em 2012. Objetivo Avaliar as tendencias do consumo de analgesicos em um hospital de ensino terciario e o impacto economico associado. Metodos Est
Autor:
A. De Lorenzo Pinto, A Castuera Gil, A Herranz Alonso, M Sanjurjo Sáez, I Miguens Blanco, R. García Sánchez, C Ortega Navarro, B Somoza
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Flecainide is commonly used for conversion of recent onset ( Aim and objectives To evaluate successful cardioversion in patients treated with vernakalant or oral flecainide with recent onset AF attending the ED. Material and
Publikováno v:
Journal of healthcare quality research. 36(2)
Autor:
R. García Sánchez, A Melgarejo Ortuño, S García Sánchez, Má Amor García, C Ortega Navarro, FJ Garcia Moreno, P Ruiz Briones, M Sanjurjo Sáez, A Herranz Alonso, Á Narrillos Moraza
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Due to the rising rate of antibiotic resistance over the past years, healthcare authorities have developed different strategies to solve this problem. In Spain, the Heath Care Service of Madrid (SERMAS) published the ‘Anti
Autor:
Roberto Alonso, C Ortega-Navarro, María Sanjurjo-Sáez, Esther Chamorro-de-Vega, Carmen Guadalupe Rodríguez-González, Ana Herranz-Alonso
Publikováno v:
The Annals of pharmacotherapy. 54(7)
Background: Real-life data on single-tablet regimen (STR) dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) is scarce, and concerns about DTG neuropsychiatric adverse events (NP-AEs) have recently arisen. Objective: To explore the effectiveness and safe
Publikováno v:
Journal of Healthcare Quality Research. 36:117-118